{
    "medicine_id": "748b3ed563d9717f4a7f797d9b168e1fd0d69692",
    "platform_id": "DB08834",
    "metadata": {
        "name": "Erivedge 150 mg 1 Capsule",
        "composition": "150 mg 1 Tauroursodeoxycholic acid",
        "clinical_particulars": {
            "therapeutic_indications": "Used in the treatment of cholesterol gallstones Tauroursodeoxycholic acid is also being investigated for use in several conditions such as Primary Biliary Cirrhosis PBC insulin resistance amyloidosis Cystic Fibrosis Cholestasis and Amyotrophic Lateral Sclerosis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding and bruising can be increased when Drotrecogin alfa is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding and bruising can be increased when Streptokinase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dicoumarol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding and bruising can be increased when Argatroban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ardeparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding and bruising can be increased when Phenindione is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fondaparinux is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding and bruising can be increased when Pentosan polysulfate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding and bruising can be increased when Phenprocoumon is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding and bruising can be increased when Heparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding and bruising can be increased when Acenocoumarol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding and bruising can be increased when 4 hydroxycoumarin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fibrinolysin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding and bruising can be increased when Idraparinux is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding and bruising can be increased when Astaxanthin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding and bruising can be increased when Apixaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding and bruising can be increased when Otamixaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding and bruising can be increased when Amediplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding and bruising can be increased when Danaparoid is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dalteparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tinzaparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ferulic acid is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding and bruising can be increased when R warfarin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ethyl biscoumacetate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nadroparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ditazole is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding and bruising can be increased when Potassium citrate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding and bruising can be increased when Sodium citrate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dextran is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding and bruising can be increased when Bemiparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding and bruising can be increased when Parnaparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding and bruising can be increased when Desirudin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding and bruising can be increased when Antithrombin Alfa is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein C is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Antithrombin III human is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding and bruising can be increased when Letaxaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding and bruising can be increased when Darexaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding and bruising can be increased when Monteplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding and bruising can be increased when Gabexate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding and bruising can be increased when Brinase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding and bruising can be increased when Clorindione is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding and bruising can be increased when Diphenadione is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tioclomarol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding and bruising can be increased when Melagatran is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding and bruising can be increased when Saruplase is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding and bruising can be increased when S Warfarin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edetate calcium disodium anhydrous is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dabigatran is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding and bruising can be increased when Zinc citrate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding and bruising can be increased when Troxerutin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edetic acid is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding and bruising can be increased when Reviparin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of adverse effects can be increased when Eptifibatide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of adverse effects can be increased when Ticlopidine is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of adverse effects can be increased when Clopidogrel is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of adverse effects can be increased when Tirofiban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of adverse effects can be increased when Dipyridamole is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Iloprost is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of adverse effects can be increased when Cilostazol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of adverse effects can be increased when Ridogrel is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of adverse effects can be increased when Resveratrol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of adverse effects can be increased when Nimesulide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of adverse effects can be increased when Tesmilifene is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of adverse effects can be increased when Defibrotide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of adverse effects can be increased when Beraprost is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of adverse effects can be increased when Ibudilast is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of adverse effects can be increased when Andrographolide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Caplacizumab is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of adverse effects can be increased when Prasugrel is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of adverse effects can be increased when Cangrelor is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of adverse effects can be increased when Tranilast is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of adverse effects can be increased when Triflusal is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of adverse effects can be increased when Ticagrelor is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of adverse effects can be increased when Vorapaxar is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of adverse effects can be increased when Trapidil is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of adverse effects can be increased when Naftopidil is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of adverse effects can be increased when Ifetroban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Ketanserin is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of adverse effects can be increased when Indobufen is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of adverse effects can be increased when Butylphthalide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of adverse effects can be increased when Ramatroban is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of adverse effects can be increased when Picotamide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of adverse effects can be increased when Cloricromen is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of adverse effects can be increased when Linsidomine is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of adverse effects can be increased when Buflomedil is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of adverse effects can be increased when Relcovaptan is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11081",
                        "description": "Aluminum chloride can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "Colestipol can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00658",
                        "description": "Sevelamer can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00930",
                        "description": "Colesevelam can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01432",
                        "description": "Cholestyramine can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Megestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Ethynodiol diacetate"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Gestodene"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Dienogest"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norethynodrel"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norgestrel"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Gestrinone"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Lynestrenol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Chlormadinone"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norgestrienone"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Quingestanol"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Demegestone"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Nomegestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Etofibrate"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Ciprofibrate"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Fenofibric acid"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Sucralfate"
                    },
                    {
                        "drugbank-id": "DB00516",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Bentoquatam"
                    },
                    {
                        "drugbank-id": "DB01575",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Kaolin"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Potassium alum"
                    },
                    {
                        "drugbank-id": "DB11239",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11306",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Bentonite"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13654",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Montmorillonite"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminium phosphate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}